Zelira Therapeutics Ltd News

Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government's R&D Tax Incentive Scheme

Zelira Therapeutics (ASX:ZLD) secured a AU$919,000 cash refund under the Australian government's research and development tax incentive scheme, according to a Monday filing with the Australian Securit

MT NewswiresApr 14 21:48 ET

Zelira Therapeutics Secures Grant Funding for Cannabinoid Product

Zelira Therapeutics (ASX:ZLD) secured a second trance grant funding worth $819,000 from the 2011 Forman Trust via a special purpose vehicle for its cannabinoid-based product Hope 1, the biopharmaceuti

MT NewswiresJan 7 21:14 ET

It's Unlikely That The CEO Of Zelira Therapeutics Limited (ASX:ZLD) Will See A Huge Pay Rise This Year

Yahoo FinanceNov 8, 2023 15:38 ET

TMH Market Close: Zelira Therapeutics (ASX:ZLD) Skyrockets 224 per Cent, Inflation Sits at 6.8 per Cent

The Market HeraldMay 31, 2023 02:55 ET

Zelira Therapeutics (ASX:ZLD) Raises $1.77m Through US-based Investors

The Market HeraldMar 14, 2023 23:14 ET

Zelira Therapeutics (ASX:ZLD) Promotes Greg Blake as Executive Director

The Market HeraldFeb 19, 2023 23:26 ET

Zelira Therapeutics (ASX:ZLD) Secures US$8.6m in Funding for HOPE Clinical Trials

The Market HeraldFeb 14, 2023 20:26 ET